glp 1 tirzepitide FDA says shortage of GLP-1 drug tirzepatide is over Expert GLP-1 Tirzepatide Weight Loss
Description
The immediate fallout was stark: HIMS shares plunged nearly 20% on February 9, 2026, dropping to $19.33 within a single trading day, and currently trade at $15.63
Retatrutide has not yet been studied in a dedicated sleep apnea trial, but given its greater weight loss, the expectation is that sleep apnea improvements would be at least as significant as those seen with tirzepatide, possibly more so
[DOI] [PubMed] [Google Scholar] 52
You can take an example of using a key to open a rusty lock in this case
Any intervention that produces 20%+ weight loss will involve some lean tissue reduction
